MN Community Measurement (MNCM) invites you to provide feedback on the newly developed measure specifications for the Controlling the Impact of COPD on Health Status measure.
The measure was developed by a MNCM-convened, multi-stakeholder COPD Measure Development Workgroup and after public comment it will move onto pilot testing in primary care and specialty practices. The public comment period will conclude on Sunday, September 18, at 11:59 p.m. CST.
National Quality Forum (NQF) Measure Incubator ™ convened the COPD project with MNCM as the measure developer and steward. The project focuses on the development and testing of a performance measure using an appropriate COPD patient-reported outcome (PRO) as a measure of clinician practice outcomes. GlaxoSmithKline, a global leader in respiratory disease, is also collaborating with the Incubator as the sponsor of the project.
A critical element of developing and testing measures by MNCM is the opportunity for the public to review proposed specifications and recommend changes or clarifications. We are seeking public comment on the measure specifications. All comments will be reviewed for consideration.
Feedback should be submitted to email@example.com by Sunday, September 18 at 11:59 p.m. CST.
More about the NQF Measure Incubator
The NQF Measure Incubator is an innovative effort that facilitates efficient measure development and testing through collaboration and partnership. By connecting groups interested in particular measure concepts with measure development experts, financial and technical resources, and data, the Measure Incubator seeks to address important aspects of care for which quality measures are underdeveloped or non-existent. In leading the Measure Incubator, NQF’s role is to facilitate the work of others; NQF itself will not develop measures.